We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
California Governor Gavin Newsom has named an 11-person scientific review panel to verify the safety of any FDA-approved COVID-19 vaccine before it is distributed in the state. Read More
Brazil’s President Jair Bolsonaro announced Wednesday that his government will not purchase a COVID-19 vaccine developed by Beijing-based Sinovac, just one day after the country’s health minister announced it would be placing an order. Read More
The Department of Justice (DOJ) announced an $8.3 billion settlement deal with Purdue Pharma Wednesday to resolve criminal and civil probes into the OxyContin manufacturer, which some critics view as insufficient punishment for the company and its owners, the Sackler family. Read More
Moderna CEO Stéphane Bancel said that the drugmaker’s COVID-19 vaccine candidate could receive an Emergency Use Authorization (EUA) in December if all goes according to plan, with interim data expected out next month. Read More
The Government Accountability Office (GAO) on Monday agreed to begin looking into allegations that the Trump administration exerted political pressure on the FDA and Centers for Disease Control and Prevention (CDC) to influence pandemic-related policies, following a request by three Democrat senators. Read More
Catalyst Pharmaceuticals has filed a patent infringement lawsuit against competitor Jacobus Pharmaceutical over the latter’s Ruzurgi (amifampridine) tablets. Read More
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended ten medicines for authorization by the European agency, including two investigational cell therapies and two antiretrovirals. Read More